Conversely, ADAR1 p150 overexpression in PC9 cells enhanced ERK phosphorylation and increased c-FOS and MMP-9 expression.<h4>Conclusions</h4>High ADAR1 expression is closely associated with poor prognosis and distant metastasis in NSCLC patients. Here, FOS is linked to non-small cell lung carcinoma.